SeraSeal is an innovative primary haemostatic agent that is designed to stop bleeding on contact and within seconds for arterial haemorrhages.
It is comprised of Agar and Bovine Factor proteins Il a, VII a, IXa and X a and acts as a catalyst in the clot formation process.
This single component system can tackle any bleeding situation with the potential to save many lives.
When seconds count, SeraSeal can make the difference between life and death.